Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Feorillo Galivo

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Human Gene Therapy|November 20, 2009
Interference of CD40L-mediated tumor immunotherapy by oncolytic vesicular stomatitis virusFeorillo Galivo, Rosa Maria Diaz, Uma Thanarajasingam, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 9, 2017
Treg Depletion-enhanced IL-2 Treatment Facilitates Therapy of Established Tumors Using Systemically Delivered Oncolytic VirusTimothy Kottke, Feorillo Galivo, Phonphimon Wongthida, et al.
Nature Biotechnology|March 20, 2012
Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanomaJose Pulido, Timothy Kottke, Jill Thompson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 24, 2008
Treg depletion-enhanced IL-2 treatment facilitates therapy of established tumors using systemically delivered oncolytic virusTimothy Kottke, Feorillo Galivo, Phonphimon Wongthida, et al.
Nature Medicine|June 21, 2011
Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumorsTimothy Kottke, Fiona Errington, Jose Pulido, et al.
Nature Medicine|December 11, 2007
Purging metastases in lymphoid organs using a combination of antigen-nonspecific adoptive T cell therapy, oncolytic virotherapy and immunotherapyJian Qiao, Timothy Kottke, Candice Willmon, et al.
JCI Insight|November 15, 2019
Using a barcoded AAV capsid library to select for clinically relevant gene therapy vectorsKatja Pekrun, Gustavo De Alencastro, Qing-Jun Luo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 2, 2008
Use of biological therapy to enhance both virotherapy and adoptive T-cell therapy for cancerTimothy Kottke, Rosa M Diaz, Karen Kaluza, et al.
Stem Cell Research|April 9, 2013
Generation of islet-like cells from mouse gall bladder by direct ex vivo reprogrammingRaymond D Hickey, Feorillo Galivo, Jonathan Schug, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
Immune-mediated antitumor activity of reovirus is required for therapy and is independent of direct viral oncolysis and replicationRobin J Prestwich, Elizabeth J Ilett, Fiona Errington, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Human Gene Therapy|November 20, 2009
Interference of CD40L-mediated tumor immunotherapy by oncolytic vesicular stomatitis virusFeorillo Galivo, Rosa Maria Diaz, Uma Thanarajasingam, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 9, 2017
Treg Depletion-enhanced IL-2 Treatment Facilitates Therapy of Established Tumors Using Systemically Delivered Oncolytic VirusTimothy Kottke, Feorillo Galivo, Phonphimon Wongthida, et al.
Nature Biotechnology|March 20, 2012
Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanomaJose Pulido, Timothy Kottke, Jill Thompson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 24, 2008
Treg depletion-enhanced IL-2 treatment facilitates therapy of established tumors using systemically delivered oncolytic virusTimothy Kottke, Feorillo Galivo, Phonphimon Wongthida, et al.
Nature Medicine|June 21, 2011
Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumorsTimothy Kottke, Fiona Errington, Jose Pulido, et al.
Nature Medicine|December 11, 2007
Purging metastases in lymphoid organs using a combination of antigen-nonspecific adoptive T cell therapy, oncolytic virotherapy and immunotherapyJian Qiao, Timothy Kottke, Candice Willmon, et al.
JCI Insight|November 15, 2019
Using a barcoded AAV capsid library to select for clinically relevant gene therapy vectorsKatja Pekrun, Gustavo De Alencastro, Qing-Jun Luo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 2, 2008
Use of biological therapy to enhance both virotherapy and adoptive T-cell therapy for cancerTimothy Kottke, Rosa M Diaz, Karen Kaluza, et al.
Stem Cell Research|April 9, 2013
Generation of islet-like cells from mouse gall bladder by direct ex vivo reprogrammingRaymond D Hickey, Feorillo Galivo, Jonathan Schug, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
Immune-mediated antitumor activity of reovirus is required for therapy and is independent of direct viral oncolysis and replicationRobin J Prestwich, Elizabeth J Ilett, Fiona Errington, et al.
Pageof 2